2m 2m 2m 2m 2m 2m 2m
CNBX Pharm (CNBX)
OTC
$0.0001$0.00 (0.00%)
Price as of Aug 03, 2026- $160,576.00Market Cap
- -80.00%1-Year Change
- BiotechnologyIndustry
CNBX Pharm (CNBX)
$0.0001$0.00 (0.00%)
CNBX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | $0.00 (0.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 1,010,166 | ||
30-Day Average Volume | 27,393,548 | ||
1-Week Change | 0.00% | ||
1-Month Change | -31.03% | ||
1-Year Change | -80.00% | ||
3-Year Change | -99.33% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.6B | ||
Total Assets | $12,795.00 | ||
Market Cap | $160,576.00 | ||
Enterprise Value | $2.7M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$154,165.00 | ||
Free Cash Flow | -$47,667.00 | ||
EBIT | -$154,165.00 | ||
EBITDA | -$154,165.00 | ||
Net Working Capital | -$2.7M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -0 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 120 | ||
Last Split Date | 05/12/2022 | ||
Earnings & Revenue